The Administrative Core (Core A) will provide programmatic direction, evaluation of scientific progress, facilitate interactions among investigators, and provide administrative support to the Program as a whole. The Program consists of four individual projects (Projects 1-4), and three Cores; Core A, the Quantitative and Functional HDL Core (Core B), and the Tissue and Imaging Core (Core C). The Principal Investigator, Dr. Karin Bornfeldt, will be the Program Director and Dr. Alan Chait will be Co-Director. The Administrative Core will be responsible for the day-to-day administrative and fiscal support, and will provide financial reports and oversight of the four Projects and Cores B and C. Other functions of Core A include organizing monthly lab meetings and an annual retreat to provide coordination and communication within the Program, organizing peer review of trainees' fellowship applications to promote their careers, and maintaining a website for data sharing and communication within the Program Project and outside investigators. A Program Project Management Committee consisting of the Project Leaders will be responsible for planning and dealing with local issues. An Internal Advisory Committee will evaluate the Program Project on an annual basis to assess progress and direction. The Administrative Core will also be responsible for evaluation of the entire program by outside consultants and by an External Review Committee.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Chen, Jue
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
United States
Zip Code
Wall, Valerie Z; Barnhart, Shelley; Kanter, Jenny E et al. (2018) Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome. JCI Insight 3:
Kanter, Jenny E; Kramer, Farah; Barnhart, Shelley et al. (2018) A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. Diabetes 67:946-959
Yuan, Chujun; Hu, Jiyuan; Parathath, Saj et al. (2018) Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice. Diabetes 67:1880-1891
Rune, Ida; Rolin, Bidda; Lykkesfeldt, Jens et al. (2018) Long-term Western diet fed apolipoprotein E-deficient rats exhibit only modest early atherosclerotic characteristics. Sci Rep 8:5416
Shao, Baohai; Heinecke, Jay W (2018) Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions? Expert Rev Proteomics 15:31-40
Basu, Debapriya; Hu, Yunying; Huggins, Lesley-Ann et al. (2018) Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor. Circ Res 122:560-567
Scolaro, Bianca; Nogueira, Marina S; Paiva, Aline et al. (2018) Statin dose reduction with complementary diet therapy: A pilot study of personalized medicine. Mol Metab 11:137-144
Fang, Xiang; Dorcely, Brenda; Ding, Xi-Ping et al. (2018) Glycemic reduction alters white blood cell counts and inflammatory gene expression in diabetes. J Diabetes Complications 32:1027-1034
Wight, Thomas N (2018) A role for proteoglycans in vascular disease. Matrix Biol 71-72:396-420
Bornfeldt, Karin E; Kramer, Farah; Batorsky, Anna et al. (2018) A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis. Am J Pathol 188:343-352

Showing the most recent 10 out of 136 publications